Tidepath

Peptide library

Mitochondrial and metabolic compounds

Both are aimed at how cells make energy. In our sources, neither has a dose for injection under the skin that's been worked out in controlled studies in people.

MOTS-c is a peptide whose gene sits in mitochondria, the parts of a cell that make most of its energy, rather than in the cell's nucleus. The research we found on it centres on metabolism. NAD+ is a helper molecule, a coenzyme, involved in how cells make energy. Here it's injected, rather than taken by mouth in a form the body turns into NAD+.

Both are discussed for longevity, and in our sources neither has a dose for injection under the skin worked out in controlled studies in people. Research on the biology behind them is a different thing from evidence about injecting either one at any particular dose.

In this group

What we don't cover

These pages don't cover side effects, who shouldn't take them (contraindications), or drug interactions, apart from the FDA's notes on each: the reports it has received of health problems after NAD+ injections, and what it says about the safety of compounded MOTS-c (mixed from its ingredients by a pharmacist or doctor). Those are on their pages.

Get an early invite to Tidepath

The app isn't in the App Store yet. Leave your email for an early invite, and tips for your first month.

Get an early invite, tips and occasional news from Tidepath. Unsubscribe anytime. Privacy · Health data privacy · Sender and contact details